NOV 22, 2017 8:33 AM PST

Creating a Model of the Blood Brain Barrier

The blood-brain barrier has been referred to in research as "Holy Grail" in terms of understanding how it works. The purpose of it is to protect the brain from certain toxins; however, the flip side of that means that some drugs to treat neurological conditions like Alzheimer's, cancer, and brain trauma cannot get through its fortress-like structure.

Cells that cause cancer can get through it however, and that is why researchers are so focused on understanding how it works and trying to find ways for beneficial medicines to get past it to treat brain disorders.

So far the research has focused on making cellular models of the BBB in the lab and then being able to manipulate them to reveal the underpinnings of how they work. Models using animal cells have been the standard so far, but they aren't always ideal. Getting human tissue is also difficult, which has made the quest to develop a lab-created model a research priority. Dr. Zaynah Maherally and her team at the University of Portsmouth may have come up with a good option that comes very close to the real thing, and hopefully, it could be the way forward in treating neurological disease. Models are also useful in testing drugs since there is no risk of injury or side effects to animals or humans. They are necessary for simulating what happens when a new drug is administered. The study out of the University of Portsmouth is the product of years of intense work, and the results were recently published in the Federation of American Societies of Experimental Biology journal.

Dr. Maherally explained, in a press release, "The blood-brain barrier is strikingly complex and notoriously difficult for scientists to breach. Its role, to protect the brain, makes it difficult for most drugs to make their way into the brain to treat brain tumors. It is a dynamic structural, physiological and biochemical fortification that, in essence, protects the brain by providing multiple layers of armor, stopping molecules from entering the brain. It's highly selective in what it allows past. In a person with a brain disease like a brain tumor, or other neurological conditions such as Parkinson's disease, dementia or head injuries, the strikingly complex defense works against medics and scientists trying to deliver what could be life-saving or life-prolonging treatments."

The model developed by the team at Portsmouth is the first of its kind, and hopefully, it will be useful for neuroscience researchers. Professor Geoff Pilkington, from the University of Portsmouth, led the research and stated, "This is the first real, 3D, all-human blood-brain barrier model and it's hugely significant in our field."

The model is uniquely suited to finding out cancers metastasize from the breast or lung to the brain. It will also be a perfect medium to test nano-particle delivery of drugs and to attempt to create temporary openings in the barrier that will let medications pass into the brain. It will also shorten the time it takes to test a new drug, getting it to clinical trials faster.

University of Portsmouth, FASEB Journal, Scientific Professionals

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
DEC 21, 2019
Drug Discovery & Development
DEC 21, 2019
Magic Mushrooms Pass First Clinical Trial Against Depression
With the efficacy of selective serotonin reuptake inhibitors such as Prozac increasingly coming under question, the search for new pharmaceutical treatment...
DEC 22, 2019
Drug Discovery & Development
DEC 22, 2019
Effective Therapeutic Approved for Migraines
The U.S Food and Drug Administration has now approved a new medication for migraines. The drug is called ‘ubrogepant (Ubrelvy)’ and comes in th...
DEC 31, 2019
Neuroscience
DEC 31, 2019
How PTSD Develops in the Mind
Close 1 in 4 people who experience severe trauma develop Post Traumatic Stress Disorder (PTSD). Now, a recent study has identified how these traumatic expe...
JAN 06, 2020
Cardiology
JAN 06, 2020
Online Therapy Treats Depression in Heart Disease Patients
People suffering from cardiovascular disease (CVD) often suffer from depression too- something that can lead to a vicious cycle in which CVD can be negativ...
JAN 14, 2020
Drug Discovery & Development
JAN 14, 2020
Promising Treatment for Dementia: Antibiotics
A class of antibiotics, known as the ‘aminoglycosides’ may serve as a promising treatment for frontotemporal dementia—according to resear...
FEB 26, 2020
Neuroscience
FEB 26, 2020
Why Alzheimer's may be a Sleep Disorder
Alzheimer’s disease is a form of dementia in which amyloid-beta protein builds up in the brain, killing off surrounding neurons and causing cognitive...
Loading Comments...